EA199900305A1 - Замещенные трициклические соединения - Google Patents

Замещенные трициклические соединения

Info

Publication number
EA199900305A1
EA199900305A1 EA199900305A EA199900305A EA199900305A1 EA 199900305 A1 EA199900305 A1 EA 199900305A1 EA 199900305 A EA199900305 A EA 199900305A EA 199900305 A EA199900305 A EA 199900305A EA 199900305 A1 EA199900305 A1 EA 199900305A1
Authority
EA
Eurasian Patent Office
Prior art keywords
tricyclic compounds
substituted tricyclic
compounds
spla
mediated
Prior art date
Application number
EA199900305A
Other languages
English (en)
Other versions
EA003992B1 (ru
Inventor
Николас Дж. Бах
Робер Д. Дийяр
Сьюзн Е. Драхейм
Джон М. мл. Морин
Original Assignee
Эли Лилли Энд Компани
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Эли Лилли Энд Компани filed Critical Эли Лилли Энд Компани
Publication of EA199900305A1 publication Critical patent/EA199900305A1/ru
Publication of EA003992B1 publication Critical patent/EA003992B1/ru

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/38Heterocyclic compounds having sulfur as a ring hetero atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56Ring systems containing three or more rings
    • C07D209/80[b, c]- or [b, d]-condensed
    • C07D209/82Carbazoles; Hydrogenated carbazoles
    • C07D209/88Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/572Five-membered rings
    • C07F9/5728Five-membered rings condensed with carbocyclic rings or carbocyclic ring systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Fats And Perfumes (AREA)
  • Pyridine Compounds (AREA)

Abstract

Описывается класс новых трициклических соединений и применение таких соединений для ингибирования опосредуемого сФЛАвысвобождения жирных кислот с целью лечения таких состояний, как септический шок.Международная заявка была опубликована вместе с отчетом о международном поиске.
EA199900305A 1996-10-30 1997-10-23 Замещенные трициклические соединения EA003992B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2984996P 1996-10-30 1996-10-30
PCT/US1997/019183 WO1998018464A1 (en) 1996-10-30 1997-10-23 Substituted tricyclics

Publications (2)

Publication Number Publication Date
EA199900305A1 true EA199900305A1 (ru) 1999-12-29
EA003992B1 EA003992B1 (ru) 2003-12-25

Family

ID=21851210

Family Applications (1)

Application Number Title Priority Date Filing Date
EA199900305A EA003992B1 (ru) 1996-10-30 1997-10-23 Замещенные трициклические соединения

Country Status (26)

Country Link
EP (1) EP0839806B1 (ru)
JP (1) JP2001503055A (ru)
KR (1) KR20000049210A (ru)
CN (1) CN1233176A (ru)
AR (1) AR010050A1 (ru)
AT (1) ATE244703T1 (ru)
AU (1) AU734096B2 (ru)
BR (1) BR9713261A (ru)
CA (1) CA2269203A1 (ru)
CO (1) CO4920250A1 (ru)
CZ (1) CZ136899A3 (ru)
DE (1) DE69723393T2 (ru)
DK (1) DK0839806T3 (ru)
EA (1) EA003992B1 (ru)
ES (1) ES2202560T3 (ru)
ID (1) ID18685A (ru)
IL (1) IL129481A0 (ru)
NO (1) NO314899B1 (ru)
NZ (1) NZ335246A (ru)
PE (1) PE10999A1 (ru)
PL (1) PL332896A1 (ru)
PT (1) PT839806E (ru)
TR (1) TR199900956T2 (ru)
TW (1) TW513428B (ru)
WO (1) WO1998018464A1 (ru)
YU (1) YU19299A (ru)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2301586A1 (en) * 1997-08-28 1999-03-04 William Louis Macias Method for treatment of non-rheumatoid arthritis
HUP0102981A3 (en) 1998-03-31 2002-10-28 Shionogi & Co Pyrrolo[1,2-a]pyrazine derivatives and pharmaceutical compositions thereof
ID23219A (id) * 1998-04-17 2000-03-30 Lilly Co Eli Trisiklik tersubstitusi
DZ2769A1 (fr) * 1998-04-17 2003-12-01 Lilly Co Eli Composés tricycliques substitués.
SK16342000A3 (sk) 1998-05-01 2002-04-04 Eli Lilly And Company Liečivo na liečbu zápalového ochorenia čreva obsahujúce 1H-indol-3-glyoxylamidy
EP1085021A4 (en) 1998-05-21 2003-01-08 Shionogi & Co DERIVATIVES OF PYRROLO 1,2-B] PYRIDAZINE, WITH INHIBITOR EFFECT ON SPLA 2?
EP1157704B1 (en) 1998-10-14 2006-06-14 Shionogi & Co., Ltd. Spla2 inhibitors for the treatment of ischaemic reperfusion injury
EP1140943B1 (en) * 1998-12-22 2003-08-13 Eli Lilly And Company Substituted pyrroloindoles
AU6015600A (en) 1999-07-19 2001-02-05 Shionogi & Co., Ltd. Tricyclic compounds having spla2-inhibitory activities
JP4636522B2 (ja) 1999-08-02 2011-02-23 塩野義製薬株式会社 sPLA2阻害作用を有する三環式化合物
WO2001014378A1 (fr) 1999-08-23 2001-03-01 Shionogi & Co., Ltd. DERIVES DE PYRROLOTRIAZINE A ACTIVITES INHIBANT sPLA¿2?
MY125942A (en) 1999-09-07 2006-09-29 Upjohn Co Aminoalkoxy carbazoles for the treatment of cns diseases
US6756376B1 (en) 1999-11-15 2004-06-29 Shionogi & Co., Ltd. Tricyclic azaindolizine derivatives having an sPLA2-inhibitory activities
AU2728301A (en) * 2000-01-06 2001-07-16 Eli Lilly And Company Combination therapy for the treatment of inflammatory and respiratory diseases
US7026318B2 (en) 2000-06-29 2006-04-11 Shionogi & Co., Ltd. Compounds exhibiting X-type sPLA2 inhibiting effect
WO2002000256A1 (en) 2000-06-29 2002-01-03 Shionogi & Co., Ltd. Remedies for cirrhosis
US6872743B2 (en) 2000-12-18 2005-03-29 Eli Lilly And Company sPLA2 inhibitors
TWI314457B (ru) 2001-03-19 2009-09-11 Shionogi & Co
AUPS282602A0 (en) 2002-06-07 2002-06-27 Garvan Institute Of Medical Research Method of inhibiting cell proliferation
ATE534646T1 (de) 2004-10-29 2011-12-15 Zeria Pharm Co Ltd Carbazolderivat, solvat davon und pharmazeutisch unbedenkliches salz davon
WO2016203468A1 (en) * 2015-06-15 2016-12-22 Raziel Therapeutics Ltd. Carbazole derivatives for the treatment of fibrotic diseases and related symptoms, and conditions thereof
CN112409493B (zh) * 2020-08-12 2022-09-30 浙江工业大学 一种重组融合酶及其在乙醛酸甲酯合成中的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3479391A (en) * 1966-10-03 1969-11-18 Squibb & Sons Inc Delta**3,14-17alpha-hydroxy-norprogesterone and esters
US3979391A (en) * 1972-11-22 1976-09-07 Sterling Drug Inc. 1,2,3,4-Tetrahydrocarbazoles
US3939177A (en) * 1972-11-22 1976-02-17 Sterling Drug Inc. 4-Aminomethyl-9-benzyl-1,2,3,4-tetrahydrocarbazoles
US5420289A (en) * 1989-10-27 1995-05-30 American Home Products Corporation Substituted indole-, indene-, pyranoindole- and tetrahydrocarbazole-alkanoic acid derivatives as inhibitors of PLA2 and lipoxygenase
IL109311A0 (en) * 1993-04-16 1994-07-31 Lilly Co Eli 1H-indole-3-acetamide sPla2 inhibitors
IL109309A (en) * 1993-04-16 2000-06-29 Lilly Co Eli 1-H-indole-3-acetic acid hydrazide SPLA2 inhibitors and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
TR199900956T2 (xx) 1999-07-21
ID18685A (id) 1998-04-30
DE69723393D1 (de) 2003-08-14
CZ136899A3 (cs) 1999-09-15
PE10999A1 (es) 1999-02-10
KR20000049210A (ko) 2000-07-25
WO1998018464A1 (en) 1998-05-07
IL129481A0 (en) 2000-02-29
AR010050A1 (es) 2000-05-17
EP0839806A1 (en) 1998-05-06
YU19299A (sh) 2000-03-21
CN1233176A (zh) 1999-10-27
NO314899B1 (no) 2003-06-10
AU734096B2 (en) 2001-06-07
NO991831D0 (no) 1999-04-16
CO4920250A1 (es) 2000-05-29
ATE244703T1 (de) 2003-07-15
TW513428B (en) 2002-12-11
NZ335246A (en) 2001-09-28
JP2001503055A (ja) 2001-03-06
ES2202560T3 (es) 2004-04-01
PL332896A1 (en) 1999-10-25
PT839806E (pt) 2003-11-28
DE69723393T2 (de) 2004-06-09
EP0839806B1 (en) 2003-07-09
AU5149498A (en) 1998-05-22
NO991831L (no) 1999-06-21
CA2269203A1 (en) 1998-05-07
EA003992B1 (ru) 2003-12-25
BR9713261A (pt) 2000-03-28
DK0839806T3 (da) 2003-10-27

Similar Documents

Publication Publication Date Title
EA199900305A1 (ru) Замещенные трициклические соединения
EA199900303A2 (ru) Замещенные трициклические соединения
EA199900324A1 (ru) Комбинированная терапия для лечения психозов
EA200200097A1 (ru) Имидазоимидазолы и триазолы в качестве противовоспалительных агентов
EA200500249A1 (ru) Применение соединений для лечения заболевания, опосредованного vcam-1
EA200001245A1 (ru) КОМПОЗИЦИИ НА ОСНОВЕ ПИРРОЛО [2,3d] ПИРИМИДИНОВ И ИХ ПРИМЕНЕНИЕ
ATE246501T1 (de) Pyrrole als spla2 inhibitoren
EA200300171A1 (ru) Циклопентаноиндолы, композиции, содержащие данные соединения, и способы лечения
EA199800667A1 (ru) Новые фенантридины
EA199900936A1 (ru) Фунгицидные трифторметилалкиламинотриазолопиримидины
EA199801031A1 (ru) Ингибиторы протеинфарнезилтрансферазы
BR9508298A (pt) Inibidores de indolizina de spla2
EA200000251A1 (ru) Производные резорцинола
DE122009000012I1 (de) Substituierte pyrazolyl-benzolsulfonamide zur behandlung von entzundungen.
EA199900381A1 (ru) Арил(тио)эфиры галогенпиримидина в качестве пестицидов
EA199900421A1 (ru) Бензонафтиридины в качестве бронхиальных терапевтических средств
EA200100732A1 (ru) Противовоспалительные и иммуносупрессорные соединения, ингибирующие клеточную адгезию
EA199901013A1 (ru) Гели пролонгированного действия
EA199900362A1 (ru) Новые соединения, полезные для использования в качестве нейрозащитных средств
ES2058191T3 (es) Acidos 2-fenil-4-quinolincarboxilicos substituidos.
ES2139669T3 (es) Nuevos derivados triciclicos de indan-2-mercaptoacetilamida 2-substituidos utiles como inhibidores de la encefalinasa.
ATE234850T1 (de) Phenylglyoxamide als spla2-inhibitoren
DK0938534T3 (da) Anvendelse af et additiv til forbedring af svære oliers egenskaber
EA199800753A1 (ru) Бензотиофены, составы их содержащие и способы с их использованием
EA199900241A1 (ru) ЗАМЕЩЕННЫЕ 1,2,3,4-ТЕТРАГИДРО-2-ДИБЕНЗОФУРАНАМИНЫ И 2-АМИНОЦИКЛОГЕПТА [b] БЕНЗОФУРАНЫ

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU